pacritinib
Sign in to saveAlso known as SB-1518, SB1518, Vonjo
Pacritinib, sold under the brand name Vonjo, is an anti-cancer medication used to treat myelofibrosis.
Key facts
- Drug.image
- Pacritinib skeletal.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 230
- Drug.tradename
- Vonjo
- Drug.DailyMedID
- Pacritinib
- Drug.routes_of_administration
- By mouth
- Drug.ATC_prefix
- L01
- Drug.ATC_suffix
- EJ03
- Drug.legal_US
- Rx-only
- Drug.CAS_number
- 937272-79-2
- Drug.PubChem
- 46216796
- Drug.DrugBank
- DB11697
- Drug.ChemSpiderID
- 28518965
- Drug.UNII
- G22N65IL3O
- Drug.KEGG
- D11768
- Drug.ChEBI
- 231350 =
- Drug.ChEMBL
- 2035187
- Drug.PDB_ligand
- 6T3
via Wikipedia infobox
Wikidata facts
- Mass
- 472.247441
Show 4 more facts
- chemical formula
- C₂₈H₃₂N₄O₃
- isomeric SMILES
- C1CCN(C1)CCOC2=C3COC/C=C/COCC4=CC=CC(=C4)C5=NC(=NC=C5)NC(=C3)C=C2
- canonical SMILES
- C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC=CC(=C4)C5=NC(=NC=C5)NC(=C3)C=C2
- Commons category
- Pacritinib
Sources (2)
via Wikidata · CC0
~2 min read
Article
6 sectionsContents
- Medical uses
- History
- Society and culture
- Names
- References
- External links
Pacritinib, sold under the brand name Vonjo, is an anti-cancer medication used to treat myelofibrosis.
It is a macrocyclic protein kinase inhibitor. It mainly inhibits Janus kinase 2 (JAK2) and Fms-like tyrosine kinase 3\CD135 (FLT3).
Connections
interferon gamma
Entity
peginterferon alfa-2a
Entity
interferon type I
Entity
JAK2
Gene
momelotinib
Entity
medication
Entity
public domain
Entity
digital object identifier
Entity
leukemia
Entity
chemical formula
Entity
chemotherapy
Entity
lymphatic system
Entity
molar mass
Entity
Q180686
Entity
lymphoma
Entity
apoptotic process
Entity
CAS Registry Number
Entity
erythropoietin
Gene
PubChem
Entity
United States Food and Drug Administration
Entity